Product
Oncology
Fourth-generation sequencers are increasingly being used in the field of oncology research. Sequencing of circulating tumor DNA (ctDNA) enables non-invasive detection of tumor mutations, providing an effective means for early cancer screening. Gene panel analysis can quickly and accurately identify mutations in multiple tumor-associated genes, helping to develop individualized therapies. In addition, mRNA sequencing can reveal changes in gene expression in tumor cells, providing insight into understanding the mechanisms of tumor development.
Circulating tumor DNA (ctDNA) Gene Panel mRNA Atlas
Copyright ©Axbio Inc. All rights reserved.